ARRY-334543,
VARLITINIB,
845272-21-1,
ARRY-334543,
ARRY334543,
ARRY 334543,
ARRY-543,
Varlitinib (ARRY334543),
UNII-846Y8197W1,
ASLAN-001,
846Y8197W1,
(R)-N4-(3-chloro-4-(thiazol-2-ylmethoxy)phenyl)-N6-(4-methyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine,
Varlitinib [USAN:INN],
Varlitinib free base,
Varlitinib (USAN/INN),
MLS006011274,
GTPL7645,
SCHEMBL1384578,
CHEMBL2103842,
SYN1192,
4-N-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-6-N-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]quinazoline-4,6-diamine,
EX-A1005,
BDBM50205268,
s2755,
ZINC13980035,
AKOS027250815,
CS-5222,
DB05944,
SB16600,
NCGC00346724-01,
NCGC00346724-02,
BC600561,
HY-10530,
SMR004703024,
FT-0772190,
SW219901-1,
D09689,
4,6-Quinazolinediamine, N(sup 4)-(3-chloro-4-(2-thiazolylmethoxy)phenyl)-N(sup 6)-((4R)-4,5- dihydro-4-methyl-2-oxazolyl)-,
N(sup 4)-(3-Chloro-4-(thiazol-2-ylmethoxy)phenyl)-N(sup 6)-((4R)-4-methyl-4,5-dihydrooxazol-2- yl)quinazoline-4,6-diamine,
Varlitinib [USAN],
D00NYJ,
C22H19ClN6O2S,
VX-765,
ACN-039815,
A8365,